Your browser doesn't support javascript.
Testing Practices for Fungal Respiratory Infections and SARS-CoV-2 among Infectious Disease Specialists, United States.
Benedict, Kaitlin; Williams, Samantha; Beekmann, Susan E; Polgreen, Philip M; Jackson, Brendan R; Toda, Mitsuru.
  • Benedict K; Mycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA.
  • Williams S; Mycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA.
  • Beekmann SE; Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA.
  • Polgreen PM; Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA.
  • Jackson BR; Mycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA.
  • Toda M; Mycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA.
J Fungi (Basel) ; 7(8)2021 Jul 27.
Article in English | MEDLINE | ID: covidwho-1335134
ABSTRACT
In an online poll, 174 infectious disease physicians reported that testing frequencies for coccidioidomycosis, histoplasmosis, blastomycosis, and cryptococcosis were similar before and during the COVID-19 pandemic, indicating that these physicians remain alert for these fungal infections and were generally not concerned about the possibility of under-detection.
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Language: English Year: 2021 Document Type: Article Affiliation country: Jof7080605

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Language: English Year: 2021 Document Type: Article Affiliation country: Jof7080605